0 Erwähnungen diese Woche
0
Social
News
Blog
Bristol Myers Squibb to buy RayzeBio in $4.1 billion cash deal
vor 6d
mRNA melanoma vaccine cuts recurrence risk by 44% in interim Phase 3 data
